Cargando…
CXCR4 as a novel target in immunology: moving away from typical antagonists
CXCR4 has been a target of interest in drug discovery for numerous years. However, so far, most if not all studies focused on finding antagonists of CXCR4 function. Recent studies demonstrate that targeting a minor allosteric pocket of CXCR4 induces an immunomodulating effect in immune cells express...
Autores principales: | Caspar, Birgit, Cocchiara, Pietro, Melet, Armelle, Van Emelen, Kristof, Van der Aa, Annegret, Milligan, Graeme, Herbeuval, Jean-Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Newlands Press Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298491/ https://www.ncbi.nlm.nih.gov/pubmed/35875591 http://dx.doi.org/10.4155/fdd-2022-0007 |
Ejemplares similares
-
Computing - moving away from the mainframe
Publicado: (1994) -
Moving Away from Amyloid Beta to Move on in Alzheimer Research
por: Moreno-Treviño, María G., et al.
Publicado: (2015) -
Chemokine receptor CXCR4 oligomerization is disrupted selectively by the antagonist ligand IT1t
por: Ward, Richard J., et al.
Publicado: (2020) -
Crohn’s Strictures—Moving Away from the Knife
por: Stenke, Emily, et al.
Publicado: (2017) -
Moving away from zero COVID in China
por: Burki, Talha
Publicado: (2023)